Leading private capital initiatives with a focus on growth-stage healthcare and tech companies, he combines operational leadership, portfolio company governance, and deal execution experience. Scott M. Freund has served in senior operating and investment roles across healthcare services and healthtech, contributing to M&A, strategic partnerships and board oversight. He is known for aligning management incentives with growth capital deployment and improving commercial metrics to prepare exits to strategic buyers and public markets. Markets view him as a pragmatic operator-investor capable of bridging clinical strategy and commercial scale.
Leading private capital initiatives with a focus on growth-stage healthcare and tech companies, he combines operational leadership, portfolio company governance, and deal execution experience. Scott M. Freund has served in senior operating and investment roles across healthcare services and healthtech, contributing to M&A, strategic partnerships and board oversight. He is known for aligning management incentives with growth capital deployment and improving commercial metrics to prepare exits to strategic buyers and public markets. Markets view him as a pragmatic operator-investor capable of bridging clinical strategy and commercial scale.
Focuses on growth-stage healthcare and healthtech opportunities where operational improvement and clinical-commercial alignment can drive valuation uplift. Prefers sector-aware, control-oriented growth capital and minority-plus investments that pair capital with board-level governance and incentive alignment. Emphasizes measurable commercial KPIs, disciplined exit orientation toward strategics and IPOs, and pragmatic risk mitigation via active portfolio operating involvement and staged capital deployment.
Focuses on growth-stage healthcare and healthtech opportunities where operational improvement and clinical-commercial alignment can drive valuation uplift. Prefers sector-aware, control-oriented growth capital and minority-plus investments that pair capital with board-level governance and incentive alignment. Emphasizes measurable commercial KPIs, disciplined exit orientation toward strategics and IPOs, and pragmatic risk mitigation via active portfolio operating involvement and staged capital deployment.
| Trades 537 | Longs Won 386/537 71% | Profit Factor 10.28 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $849,563.71 |
| Average Win $167,121.87 | Best Trade (Oct 16) $16.8M | Sharpe Ratio -244.38 |
| Average Loss -$41,540.67 | Worst Trade (Oct 16) -$707,836.81 | Z-Score 6.57 (100%) |
| Commissions $0 | Avg. Trade Length 10m 2w 5d | Expectancy $108,447.68 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.02% |
| Consecutive Losing Trades | 6,369 | 5,732 | 5,096 | 4,459 | 3,822 | 3,185 | 2,548 | 1,911 | 1,274 | 637 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 8,341 | $2.09M | $2.88M | - | $784,996.98 | 37.54% | +0.825% |
AMZN Amazon.com Inc | 3,918 | $864,169.17 | $991,606.62 | - | $127,437.45 | 14.75% | -0.656% |
ARKK ARK Innovation ETF Fund | 2,920 | $235,987.74 | $241,863.6 | - | $5,875.86 | 2.49% | -3.338% |
ARTY iShares Future AI & Tech ETF | 9,925 | $368,035.56 | $697,529 | - | $329,493.44 | 89.53% | -3.541% |
AVDE Avantis International Equity ETF | 48,456 | $3.04M | $4.38M | - | $1.34M | 43.94% | +0.489% |
AVEM Avantis Emerging Markets Equity ETF | 41,568 | $2.51M | $3.71M | - | $1.21M | 48.09% | -1.173% |
AVSC Avantis U.S. Small Cap Equity ETF | 38,244 | $2.08M | $2.67M | - | $588,856.31 | 28.32% | -0.186% |
AVUS Avantis U.S. Equity ETF | 122,099 | $12.17M | $15.78M | - | $3.61M | 29.63% | -0.393% |
BALT Inn Defined Wealth Shield Mutual Fund | 171,004 | $5.84M | $5.99M | - | $145,249.77 | 2.49% | -0.1% |
BOTZ Global X Robotics & Artificial Intelligence ETF | 6,002 | $191,823.57 | $200,316.75 | - | $8,493.18 | 4.43% | -1.082% |
| BPRE BPRE | 153,522 | $2.33M | $1.93M | - | -$401,095.44 | -17.24% | 0.0 |
BRK-B Berkshire Hathaway Inc. | 1,895 | $943,758 | $1M | - | $59,113.9 | 6.26% | +0.673% |
CAGE Calamos Autocallable Growth ETF | 81,582 | $2.33M | $2.38M | - | $53,618.43 | 2.3% | -0.765% |
CAIE Calamos Autocallable Income ETF | 47,491 | $1.27M | $1.26M | - | -$9,755.67 | -0.77% | -0.785% |
CAIQ Calamos Nasdaq Autocallable Income ETF | 45,380 | $1.17M | $1.13M | - | -$41,681.68 | -3.55% | -1.694% |
CGMU Capital Group Municipal Income ETF | 32,764 | $882,678.2 | $862,512.3 | - | -$20,165.9 | -2.28% | -0.095% |
COST Costco Wholesale Corporation | 279 | $255,860.13 | $275,908.68 | - | $20,048.55 | 7.84% | +1.116% |
CPAG F/m Compoundr U.S. Aggregate Bond ETF | 3,736 | $383,093.89 | $374,048.32 | - | -$9,045.57 | -2.36% | +0.16% |
| CPSL CPSL | 78,674 | $2.22M | $2.22M | - | $8,153.93 | 0.37% | 0.0 |
CRWV CoreWeave, Inc. | 8,654 | $1.18M | $540,399.03 | - | -$642,786.53 | -54.33% | -10.396% |